Telephone
1.858.836.5000
Address
9001 Spectrum Center Boulevard San Diego, CA 92123
Description
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 21.14 - 36.37
Trade Value (12mth)
US$9,265,139.00
1 week
4.61%
1 month
4.92%
YTD
-20.23%
1 year
-28.77%
All time high
40.79
EPS 3 yr Growth
42.000%
EBITDA Margin
31.90%
Operating Cashflow
$693m
Free Cash Flow Return
14.00%
ROIC
18.10%
Interest Coverage
22.20
Quick Ratio
1.80
Shares on Issue (Fully Dilluted)
1475m
HALO Sector
Healthcare
Next Company Report Date
01-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.35
Date | Announcements |
---|---|
31 October 22 |
FORM 10Q for Qtr ended September, 2022
×
FORM 10Q for Qtr ended September, 2022 |
31 March 23 |
Company Secretary Appointment/Resignation
×
Company Secretary Appointment/Resignation |
31 January 22 |
FORM 10Q for Qtr ended December, 2021
×
FORM 10Q for Qtr ended December, 2021 |
30 October 23 |
FORM 10Q for Qtr ended September, 2023
×
FORM 10Q for Qtr ended September, 2023 |
30 January 23 |
FORM 10Q for Qtr ended December, 2022
×
FORM 10Q for Qtr ended December, 2022 |
29 May 23 |
FORM SD
×
FORM SD |
29 April 22 |
ResMed Announces Results for the Third Quarter of FY2022
×
ResMed Announces Results for the Third Quarter of FY2022 |
29 April 22 |
Dividend/Distribution - RMD
×
Dividend/Distribution - RMD |
28 October 22 |
ResMed Announces Results for the First Quarter of FY2023
×
ResMed Announces Results for the First Quarter of FY2023 |
28 October 22 |
Dividend/Distribution - RMD
×
Dividend/Distribution - RMD |
28 May 09 |
RESMED INC. TO PRESENT AT UPCOMING CONFERENCES IN JUNE
×
RESMED INC. TO PRESENT AT UPCOMING CONFERENCES IN JUNE |
28 January 22 |
ResMed Announces Results for the Second Quarter of FY2022
×
ResMed Announces Results for the Second Quarter of FY2022 |
28 January 22 |
Dividend/Distribution - RMD
×
Dividend/Distribution - RMD |
28 April 23 |
ResMed Announces Results for the Third Quarter of FY2023
×
ResMed Announces Results for the Third Quarter of FY2023 |
28 April 23 |
Dividend/Distribution - RMD
×
Dividend/Distribution - RMD |
28 April 10 |
ResMed Inc To Present At Upcoming Conferences
×
ResMed Inc To Present At Upcoming Conferences |
27 October 23 |
ResMed Announces Results for the First Quarter of FY2024
×
ResMed Announces Results for the First Quarter of FY2024 |
27 October 23 |
Dividend/Distribution - RMD
×
Dividend/Distribution - RMD |
27 May 22 |
FORM SD
×
FORM SD |
27 January 23 |
ResMed Announces Results for the Second Quarter of FY2023
×
ResMed Announces Results for the Second Quarter of FY2023 |
27 January 23 |
Chairman Appointment/Resignation
×
Chairman Appointment/Resignation |
27 January 23 |
Dividend/Distribution - RMD
×
Dividend/Distribution - RMD |
27 January 23 |
ASR - December Quarterly and H1 FY23 result
×
ASR - December Quarterly and H1 FY23 result |
25 October 05 |
ResMed Inc. - Annual Report - 2005
×
ResMed Inc. - Annual Report - 2005 |
24 January 23 |
RMD to Report Second Quarter Fiscal 2023 Results
×
RMD to Report Second Quarter Fiscal 2023 Results |
23 November 20 |
FORM 8-K Annual Meeting Stockholders
×
FORM 8-K Annual Meeting Stockholders |
22 November 21 |
FORM 8-K Annual Meeting Stockholders
×
FORM 8-K Annual Meeting Stockholders |
21 November 23 |
ResMed Inc. Amended and Restated Bylaws
×
ResMed Inc. Amended and Restated Bylaws |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.